{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:35:35Z","timestamp":1793090135270,"version":"4.5.0"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10787-026-02219-0","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:41:15Z","timestamp":1775436075000},"page":"3129-3152","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Flavonoids and semi-synthetic derivatives targeting oncogenic inflammation: dose-response relationships, toxicological profiles, and synergistic potential"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3280-919X","authenticated-orcid":false,"given":"Polu Picheswara","family":"Rao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"key":"2219_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/CANCERS11010028","volume":"11","author":"M Abotaleb","year":"2018","unstructured":"Abotaleb M, Samuel SM, Varghese E et al (2018) Flavonoids in cancer and apoptosis. Cancers (Basel) 11:28. https:\/\/doi.org\/10.3390\/CANCERS11010028","journal-title":"Cancers (Basel)"},{"key":"2219_CR3","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/J.TOXREP.2022.03.011","volume":"9","author":"DH Abou Baker","year":"2022","unstructured":"Abou Baker DH (2022) An ethnopharmacological review on the therapeutical properties of flavonoids and their mechanisms of actions: a comprehensive review based on up to date knowledge. Toxicol Rep 9:445\u2013469. https:\/\/doi.org\/10.1016\/J.TOXREP.2022.03.011","journal-title":"Toxicol Rep"},{"key":"2219_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/1556-276X-8-102","author":"A Akbarzadeh","year":"2013","unstructured":"Akbarzadeh A, Rezaei-Sadabady R, Davaran S et al (2013) Liposome: classification, preparation, and applications. Nanoscale Res Lett. https:\/\/doi.org\/10.1186\/1556-276X-8-102","journal-title":"Nanoscale Res Lett"},{"key":"2219_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3892\/BR.2024.1745","volume":"20","author":"BA Aljabr","year":"2024","unstructured":"Aljabr BA, Zihlif M, Abu-Dahab R, Zalloum H (2024) Effect of quercetin on doxorubicin cytotoxicity in sensitive and resistant human MCF7 breast cancer cell lines. Biomed Rep 20:58. https:\/\/doi.org\/10.3892\/BR.2024.1745","journal-title":"Biomed Rep"},{"issue":"1","key":"2219_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/S40880-017-0217-4","volume":"36","author":"H Amawi","year":"2017","unstructured":"Amawi H, Ashby CR, Tiwari AK (2017) Cancer chemoprevention through dietary flavonoids: what\u2019s limiting?. Chin J Cancer 36(1):50. https:\/\/doi.org\/10.1186\/S40880-017-0217-4","journal-title":"Chin J Cancer"},{"key":"2219_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/MNFR.201700447","author":"S Andres","year":"2018","unstructured":"Andres S, Pevny S, Ziegenhagen R et al (2018) Safety aspects of the use of quercetin as a dietary supplement. Mol Nutr Food Res. https:\/\/doi.org\/10.1002\/MNFR.201700447","journal-title":"Mol Nutr Food Res"},{"key":"2219_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/PR11092771","volume":"11","author":"CMC Andr\u00e9s","year":"2023","unstructured":"Andr\u00e9s CMC, de la P\u00e9rez JM, Juan CA et al (2023) Polyphenols as antioxidant\/pro-oxidant compounds and donors of reducing species: relationship with human antioxidant metabolism. Process 2023 11:11. https:\/\/doi.org\/10.3390\/PR11092771","journal-title":"Process 2023"},{"key":"2219_CR9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/S12935-022-02677-W","volume":"22","author":"P Asgharian","year":"2022","unstructured":"Asgharian P, Tazekand AP, Hosseini K et al (2022) Potential mechanisms of quercetin in cancer prevention: focus on cellular and molecular targets. Cancer Cell Int 22:257. https:\/\/doi.org\/10.1186\/S12935-022-02677-W","journal-title":"Cancer Cell Int"},{"key":"2219_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/IJMS21114002","volume":"21","author":"M Ashrafizadeh","year":"2020","unstructured":"Ashrafizadeh M, Zarrabi A, Hushmandi K et al (2020) Association of the epithelial-mesenchymal transition (EMT) with cisplatin resistance. Int J Mol Sci 21:1\u201346. https:\/\/doi.org\/10.3390\/IJMS21114002","journal-title":"Int J Mol Sci"},{"key":"2219_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1074\/jbc.272.1.217","volume":"272","author":"YS Bae","year":"1997","unstructured":"Bae YS, Kang SW, Seo MS et al (1997) Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem 272:217\u2013221","journal-title":"J Biol Chem"},{"key":"2219_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/S12964-020-0530-4","author":"R Baghban","year":"2020","unstructured":"Baghban R, Roshangar L, Jahanban-Esfahlan R et al (2020) Tumor microenvironment complexity and therapeutic implications at a glance. Cell Commun Signal. https:\/\/doi.org\/10.1186\/S12964-020-0530-4","journal-title":"Cell Commun Signal"},{"key":"2219_CR13","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/J.CANLET.2008.03.052","volume":"269","author":"S Banerjee","year":"2008","unstructured":"Banerjee S, Li Y, Wang Z, Sarkar FH (2008) Multi-targeted therapy of cancer by genistein. Cancer Lett 269:226\u2013242. https:\/\/doi.org\/10.1016\/J.CANLET.2008.03.052","journal-title":"Cancer Lett"},{"key":"2219_CR14","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0031-9422(96)00344-5","volume":"43","author":"D Barron","year":"1996","unstructured":"Barron D, Ibrahim RK (1996) Isoprenylated flavonoids\u2014a survey. Phytochemistry 43:921\u2013982. https:\/\/doi.org\/10.1016\/S0031-9422(96)00344-5","journal-title":"Phytochemistry"},{"key":"2219_CR15","doi-asserted-by":"publisher","DOI":"10.1200\/GO-24-00312","author":"B Batlamous","year":"2025","unstructured":"Batlamous B, Lkhoyaali S, Omri L et al (2025) Clinical characteristics of toxicities of immune checkpoint inhibitors and their impact on efficacy in solid cancers: an analysis of real-world data in moroccan patients. JCO Global Oncol. https:\/\/doi.org\/10.1200\/GO-24-00312","journal-title":"JCO Global Oncol"},{"key":"2219_CR16","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","volume":"11","author":"L Bejarano","year":"2021","unstructured":"Bejarano L, Jord\u0101o MJC, Joyce JA (2021) Therapeutic targeting of the tumor microenvironment. Cancer Discov 11:933\u2013959. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-1808","journal-title":"Cancer Discov"},{"key":"2219_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/MOLECULES28166141","author":"MS Bhuia","year":"2023","unstructured":"Bhuia MS, Wilairatana P, Ferdous J et al (2023) Hirsutine, an emerging natural product with promising therapeutic benefits. Syst Rev Mol. https:\/\/doi.org\/10.3390\/MOLECULES28166141","journal-title":"Syst Rev Mol"},{"key":"2219_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/IJMS231911746","volume":"23","author":"P Biswas","year":"2022","unstructured":"Biswas P, Dey D, Biswas PK et al (2022) A comprehensive analysis and anti-cancer activities of quercetin in ROS-mediated cancer and cancer stem cells. Int J Mol Sci 2022 23:23. https:\/\/doi.org\/10.3390\/IJMS231911746","journal-title":"Int J Mol Sci 2022"},{"key":"2219_CR19","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1038\/s41467-019-11622-x","volume":"101 10","author":"NP Bondonno","year":"2019","unstructured":"Bondonno NP, Dalgaard F, Kyr\u00f8 C et al (2019) Flavonoid intake is associated with lower mortality in the danish diet cancer and health cohort. Nat Commun 2019 101 10:3651. https:\/\/doi.org\/10.1038\/s41467-019-11622-x","journal-title":"Nat Commun 2019"},{"key":"2219_CR20","doi-asserted-by":"publisher","first-page":"713","DOI":"10.2174\/0929867053202241","volume":"12","author":"B Botta","year":"2005","unstructured":"Botta B, Vitali A, Menendez P et al (2005) Prenylated flavonoids: pharmacology and biotechnology. Curr Med Chem 12:713\u2013739. https:\/\/doi.org\/10.2174\/0929867053202241","journal-title":"Curr Med Chem"},{"key":"2219_CR21","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1124\/JPET.109.161927","volume":"332","author":"SJ Brantley","year":"2010","unstructured":"Brantley SJ, Oberlies NH, Kroll DJ, Paine MF (2010) Two flavonolignans from milk thistle (Silybum marianum) inhibit CYP2C9-mediated warfarin metabolism at clinically achievable concentrations. J Pharmacol Exp Ther 332:1081\u20131087. https:\/\/doi.org\/10.1124\/JPET.109.161927","journal-title":"J Pharmacol Exp Ther"},{"key":"2219_CR22","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/CAAC.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424. https:\/\/doi.org\/10.3322\/CAAC.21492","journal-title":"CA Cancer J Clin"},{"key":"2219_CR23","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/1097-0215(20000815)87:4<595::aid-ijc21>3.0.co;2-5","volume":"87","author":"S Caltagirone","year":"2000","unstructured":"Caltagirone S, Rossi C, Poggi A et al (2000) Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int J cancer 87:595\u2013600. https:\/\/doi.org\/10.1002\/1097-0215(20000815)87:4%3C595::aid-ijc21%3E3.0.co;2-5","journal-title":"Int J cancer"},{"key":"2219_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/MOLECULES28134982","author":"S Chen","year":"2023","unstructured":"Chen S, Wang X, Cheng Y et al (2023) A review of classification, biosynthesis, biological activities and potential applications of flavonoids. Molecules. https:\/\/doi.org\/10.3390\/MOLECULES28134982","journal-title":"Molecules"},{"key":"2219_CR25","doi-asserted-by":"publisher","first-page":"640","DOI":"10.2174\/1389200211209050640","volume":"13","author":"X-W Chen","year":"2012","unstructured":"Chen X-W, Sneed B, Pan K S-Y, et al (2012) Herb-drug interactions and mechanistic and clinical considerations. Curr Drug Metab 13:640\u2013651. https:\/\/doi.org\/10.2174\/1389200211209050640","journal-title":"Curr Drug Metab"},{"key":"2219_CR26","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.7314\/APJCP.2013.14.4.2407","volume":"14","author":"F Chi","year":"2013","unstructured":"Chi F, Wu R, Zeng YC et al (2013) Post-diagnosis soy food intake and breast cancer survival: a meta-analysis of cohort studies. Asian Pac J Cancer Prev 14:2407\u20132412. https:\/\/doi.org\/10.7314\/APJCP.2013.14.4.2407","journal-title":"Asian Pac J Cancer Prev"},{"key":"2219_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1055\/S-2003-38483","volume":"69","author":"CH Choi","year":"2003","unstructured":"Choi CH, Kang G, Min YD (2003) Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginseng. Planta Med 69:235\u2013240. https:\/\/doi.org\/10.1055\/S-2003-38483","journal-title":"Planta Med"},{"key":"2219_CR28","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1093\/AJHP\/61.22.2406","volume":"61","author":"JS Choi","year":"2004","unstructured":"Choi JS, Choi BC, Choi KE (2004) Effect of quercetin on the pharmacokinetics of oral cyclosporine. Am J Health Syst Pharm 61:2406\u20132409. https:\/\/doi.org\/10.1093\/AJHP\/61.22.2406","journal-title":"Am J Health Syst Pharm"},{"key":"2219_CR29","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.biomaterials.2009.09.030","volume":"31","author":"KY Choi","year":"2010","unstructured":"Choi KY, Chung H, Min KH et al (2010) Self-assembled hyaluronic acid nanoparticles for active tumor targeting. Biomaterials 31:106\u2013114. https:\/\/doi.org\/10.1016\/j.biomaterials.2009.09.030","journal-title":"Biomaterials"},{"key":"2219_CR31","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/ONC.2016.225","volume":"36","author":"S Chouaib","year":"2017","unstructured":"Chouaib S, Noman MZ, Kosmatopoulos K, Curran MA (2017) Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer. Oncogene 36:439\u2013445. https:\/\/doi.org\/10.1038\/ONC.2016.225","journal-title":"Oncogene"},{"key":"2219_CR30","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"TC Chou","year":"2010","unstructured":"Chou TC (2010) Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 70:440\u2013446. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-1947","journal-title":"Cancer Res"},{"key":"2219_CR32","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1158\/2326-6066.CIR-18-0095","volume":"6","author":"PS Chowdhury","year":"2018","unstructured":"Chowdhury PS, Chamoto K, Kumar A, Honjo T (2018) PPAR-induced fatty acid oxidation in T cells increases the number of tumor-reactive CD8\u2009+\u2009T cells and facilitates anti-PD-1 therapy. Cancer Immunol Res 6:1375\u20131387. https:\/\/doi.org\/10.1158\/2326-6066.CIR-18-0095","journal-title":"Cancer Immunol Res"},{"key":"2219_CR33","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/NATURE01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860\u2013867. https:\/\/doi.org\/10.1038\/NATURE01322","journal-title":"Nature"},{"key":"2219_CR34","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3390\/CANCERS16030585\/S1","volume":"16","author":"EF de Morais","year":"2024","unstructured":"de Morais EF, de Oliveira LQR, de Farias Morais HG et al (2024) The anticancer potential of kaempferol: a systematic review based on in vitro studies. Cancers (Basel) 16:585. https:\/\/doi.org\/10.3390\/CANCERS16030585\/S1","journal-title":"Cancers (Basel)"},{"key":"2219_CR35","doi-asserted-by":"publisher","DOI":"10.3892\/IJMM.2023.5321","author":"S Deng","year":"2023","unstructured":"Deng S, Li J, Li L et al (2023) Quercetin alleviates lipopolysaccharide\u2013induced acute lung injury by inhibiting ferroptosis via the Sirt1\/Nrf2\/Gpx4 pathway. Int J Mol Med. https:\/\/doi.org\/10.3892\/IJMM.2023.5321. 52:","journal-title":"Int J Mol Med"},{"key":"2219_CR36","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/NRC.2016.4","volume":"16","author":"DA Drew","year":"2016","unstructured":"Drew DA, Cao Y, Chan AT (2016) Aspirin and colorectal cancer: the promise of precision chemoprevention. Nat Rev Cancer 16:173\u2013186. https:\/\/doi.org\/10.1038\/NRC.2016.4","journal-title":"Nat Rev Cancer"},{"key":"2219_CR37","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3945\/JN.109.117655","volume":"140","author":"S Egert","year":"2010","unstructured":"Egert S, Boesch-Saadatmandi C, Wolffram S et al (2010) Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype. J Nutr 140:278\u2013284. https:\/\/doi.org\/10.3945\/JN.109.117655","journal-title":"J Nutr"},{"key":"2219_CR38","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/J.NUTRES.2004.07.005","volume":"24","author":"I Erlund","year":"2004","unstructured":"Erlund I (2004) Review of the flavonoids quercetin, hesperetin, and naringenin. Dietary sources, bioactivities, bioavailability, and epidemiology. Nutr Res 24:851\u2013874. https:\/\/doi.org\/10.1016\/J.NUTRES.2004.07.005","journal-title":"Nutr Res"},{"key":"2219_CR39","doi-asserted-by":"publisher","first-page":"7033","DOI":"10.1158\/1078-0432.CCR-05-0406","volume":"11","author":"MZ Fang","year":"2005","unstructured":"Fang MZ, Chen D, Sun Y et al (2005) Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Clin Cancer Res 11:7033\u20137041. https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-0406","journal-title":"Clin Cancer Res"},{"key":"2219_CR40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.22270\/JDDT.V11I5-S.5063","volume":"11","author":"F Farooque","year":"2021","unstructured":"Farooque F, Wasi M, Mughees MM (2021) Liposomes as drug delivery system: an updated review. J Drug Deliv Ther 11:149\u2013158. https:\/\/doi.org\/10.22270\/JDDT.V11I5-S.5063","journal-title":"J Drug Deliv Ther"},{"key":"2219_CR41","doi-asserted-by":"publisher","first-page":"6499","DOI":"10.3748\/WJG.V21.I21.6499","volume":"21","author":"MH Farzaei","year":"2015","unstructured":"Farzaei MH, Abdollahi M, Rahimi R (2015) Role of dietary polyphenols in the management of peptic ulcer. World J Gastroenterol 21:6499. https:\/\/doi.org\/10.3748\/WJG.V21.I21.6499","journal-title":"World J Gastroenterol"},{"key":"2219_CR42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/BIOM15030326","volume":"15","author":"KV Fernandez-Mu\u00f1oz","year":"2025","unstructured":"Fernandez-Mu\u00f1oz KV, S\u00e1nchez-Barrera C\u00c1, Meraz-R\u00edos M et al (2025) Natural alternatives in the treatment of colorectal cancer: a mechanisms perspective. Biomol 2025 15:15. https:\/\/doi.org\/10.3390\/BIOM15030326","journal-title":"Biomol 2025"},{"key":"2219_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-020-63448-Z","author":"M Frederick","year":"2020","unstructured":"Frederick M, Skinner HD, Kazi SA et al (2020) High expression of oxidative phosphorylation genes predicts improved survival in squamous cell carcinomas of the head and neck and lung. Sci Rep. https:\/\/doi.org\/10.1038\/S41598-020-63448-Z","journal-title":"Sci Rep"},{"key":"2219_CR44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0300-483X(02)00198-1","volume":"177","author":"G Galati","year":"2002","unstructured":"Galati G, Sabzevari O, Wilson JX, O\u2019Brien PJ (2002) Prooxidant activity and cellular effects of the phenoxyl radicals of dietary flavonoids and other polyphenolics. Toxicology 177:91\u2013104. https:\/\/doi.org\/10.1016\/S0300-483X(02)00198-1","journal-title":"Toxicology"},{"key":"2219_CR45","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/J.SCP.2017.07.002","volume":"6","author":"P Ganesan","year":"2017","unstructured":"Ganesan P, Narayanasamy D (2017) Lipid nanoparticles: Different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery. Sustain Chem Pharm 6:37\u201356. https:\/\/doi.org\/10.1016\/J.SCP.2017.07.002","journal-title":"Sustain Chem Pharm"},{"key":"2219_CR46","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","volume":"19","author":"A Garcia-Diaz","year":"2017","unstructured":"Garcia-Diaz A, Shin DS, Moreno BH et al (2017) Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression. Cell Rep 19:1189\u20131201. https:\/\/doi.org\/10.1016\/j.celrep.2017.04.031","journal-title":"Cell Rep"},{"key":"2219_CR47","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1126\/SCIENCE.AAW2367","volume":"364","author":"WS Garrett","year":"2019","unstructured":"Garrett WS (2019) The gut microbiota and colon cancer. Science 364:1133\u20131135. https:\/\/doi.org\/10.1126\/SCIENCE.AAW2367","journal-title":"Science"},{"key":"2219_CR48","doi-asserted-by":"publisher","first-page":"66680","DOI":"10.18632\/ONCOTARGET.19164","volume":"8","author":"M Gera","year":"2017","unstructured":"Gera M, Sharma N, Ghosh M et al (2017) Nanoformulations of curcumin: an emerging paradigm for improved remedial application. Oncotarget 8:66680. https:\/\/doi.org\/10.18632\/ONCOTARGET.19164","journal-title":"Oncotarget"},{"key":"2219_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/POLYM16172536","author":"M Geszke-Moritz","year":"2024","unstructured":"Geszke-Moritz M, Moritz M (2024) Biodegradable polymeric nanoparticle-based drug delivery systems: comprehensive overview, perspectives and challenges. Polymers. https:\/\/doi.org\/10.3390\/POLYM16172536","journal-title":"Polymers"},{"key":"2219_CR50","doi-asserted-by":"publisher","first-page":"840","DOI":"10.4103\/MGMJ.MGMJ_278_25","volume":"12","author":"D Ghosh","year":"2025","unstructured":"Ghosh D, Panda B, Singha PS, Ghosh R (2025) Flavonoids as therapeutic agents in cancer: insights into their antioxidant and anti-inflammatory roles. MGM J Med Sci 12:840\u2013853. https:\/\/doi.org\/10.4103\/MGMJ.MGMJ_278_25","journal-title":"MGM J Med Sci"},{"key":"2219_CR51","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/CAC2.12416","volume":"43","author":"A Goenka","year":"2023","unstructured":"Goenka A, Khan F, Verma B et al (2023) Tumor microenvironment signaling and therapeutics in cancer progression. Cancer Commun 43:525. https:\/\/doi.org\/10.1002\/CAC2.12416","journal-title":"Cancer Commun"},{"key":"2219_CR52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/J.IMMUNI.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten FR, Grivennikov SI (2019) Inflammation and cancer: triggers, mechanisms, and consequences. Immunity 51:27\u201341. https:\/\/doi.org\/10.1016\/J.IMMUNI.2019.06.025","journal-title":"Immunity"},{"key":"2219_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/MNFR.201600930","author":"G Grosso","year":"2017","unstructured":"Grosso G, Godos J, Lamuela-Raventos R et al (2017) A comprehensive meta-analysis on dietary flavonoid and lignan intake and cancer risk: Level of evidence and limitations. Mol Nutr Food Res. https:\/\/doi.org\/10.1002\/MNFR.201600930","journal-title":"Mol Nutr Food Res"},{"key":"2219_CR54","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1007\/S12672-024-01510-2","volume":"15","author":"X Hao","year":"2024","unstructured":"Hao X, Ding M, Chi C et al (2024) The potential of kaempferol in digestive system tumors: recent advances and mechanistic insights. Discov Oncol 15:658. https:\/\/doi.org\/10.1007\/S12672-024-01510-2","journal-title":"Discov Oncol"},{"key":"2219_CR55","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1016\/j.fct.2007.05.015","volume":"45","author":"M Harwood","year":"2007","unstructured":"Harwood M, Danielewska-Nikiel B, Borzelleca JF et al (2007) A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic\/carcinogenic properties. Food Chem Toxicol 45:2179\u20132205. https:\/\/doi.org\/10.1016\/j.fct.2007.05.015","journal-title":"Food Chem Toxicol"},{"key":"2219_CR56","doi-asserted-by":"publisher","first-page":"e27533","DOI":"10.1016\/J.HELIYON.2024.E27533","volume":"10","author":"H Hasnat","year":"2024","unstructured":"Hasnat H, Shompa SA, Islam MM et al (2024) Flavonoids: a treasure house of prospective pharmacological potentials. Heliyon 10:e27533. https:\/\/doi.org\/10.1016\/J.HELIYON.2024.E27533","journal-title":"Heliyon"},{"key":"2219_CR57","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw DC, Shevde LA (2019) The tumor microenvironment innately modulates cancer progression. Cancer Res 79:4557\u20134567. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-3962","journal-title":"Cancer Res"},{"key":"2219_CR58","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3945\/AN.116.012948","volume":"8","author":"GL Hostetler","year":"2017","unstructured":"Hostetler GL, Ralston RA, Schwartz SJ (2017) Flavones: food sources, bioavailability, metabolism, and bioactivity. Adv Nutr 8:423\u2013435. https:\/\/doi.org\/10.3945\/AN.116.012948","journal-title":"Adv Nutr"},{"key":"2219_CR60","doi-asserted-by":"publisher","first-page":"6815","DOI":"10.4049\/JIMMUNOL.0903991","volume":"184","author":"R-Y Huang","year":"2010","unstructured":"Huang R-Y, Yu Y-L, Cheng W-C et al (2010) Immunosuppressive effect of quercetin on dendritic cell activation and function. J Immunol 184:6815\u20136821. https:\/\/doi.org\/10.4049\/JIMMUNOL.0903991","journal-title":"J Immunol"},{"key":"2219_CR59","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.3390\/MOLECULES30051184","volume":"30","author":"L Hu","year":"2025","unstructured":"Hu L, Luo Y, Yang J, Cheng C (2025) Botanical flavonoids: efficacy, absorption, metabolism and advanced pharmaceutical technology for improving bioavailability. Molecules 30:1184. https:\/\/doi.org\/10.3390\/MOLECULES30051184","journal-title":"Molecules"},{"key":"2219_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/MOLECULES24122277","author":"M Imran","year":"2019","unstructured":"Imran M, Salehi B, Sharifi-Rad J et al (2019) Kaempferol: a key emphasis to its anticancer potential. Molecules. https:\/\/doi.org\/10.3390\/MOLECULES24122277","journal-title":"Molecules"},{"key":"2219_CR62","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.lfs.2018.07.027","volume":"208","author":"L Jia","year":"2018","unstructured":"Jia L, Huang S, Yin X et al (2018) Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction. Life Sci 208:123\u2013130. https:\/\/doi.org\/10.1016\/j.lfs.2018.07.027","journal-title":"Life Sci"},{"key":"2219_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/S12943-019-1089-9","author":"X Jing","year":"2019","unstructured":"Jing X, Yang F, Shao C et al (2019) Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. https:\/\/doi.org\/10.1186\/S12943-019-1089-9","journal-title":"Mol Cancer"},{"key":"2219_CR64","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/NRC.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R (2016) The biology and function of fibroblasts in cancer. Nat Rev Cancer 16:582\u2013598. https:\/\/doi.org\/10.1038\/NRC.2016.73","journal-title":"Nat Rev Cancer"},{"key":"2219_CR65","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.lfs.2016.01.017","volume":"146","author":"D Kashyap","year":"2016","unstructured":"Kashyap D, Tuli HS, Sharma AK (2016) Ursolic acid (UA): a metabolite with promising therapeutic potential. Life Sci 146:201\u2013213. https:\/\/doi.org\/10.1016\/j.lfs.2016.01.017","journal-title":"Life Sci"},{"key":"2219_CR66","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/J.IJPHARM.2018.06.060","volume":"548","author":"J Khan","year":"2018","unstructured":"Khan J, Alexander A, Ajazuddin et al (2018) Exploring the role of polymeric conjugates toward anti-cancer drug delivery: current trends and future projections. Int J Pharm 548:500\u2013514. https:\/\/doi.org\/10.1016\/J.IJPHARM.2018.06.060","journal-title":"Int J Pharm"},{"key":"2219_CR67","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1254\/JPHS.CRJ04003X","volume":"96","author":"HP Kim","year":"2004","unstructured":"Kim HP, Son KH, Chang HW, Kang SS (2004) Anti-inflammatory plant flavonoids and cellular action mechanisms. J Pharmacol Sci 96:229\u2013245. https:\/\/doi.org\/10.1254\/JPHS.CRJ04003X","journal-title":"J Pharmacol Sci"},{"key":"2219_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/NU12020457","author":"DM Kopustinskiene","year":"2020","unstructured":"Kopustinskiene DM, Jakstas V, Savickas A, Bernatoniene J (2020) Flavonoids as anticancer agents. Nutrients. https:\/\/doi.org\/10.3390\/NU12020457","journal-title":"Nutrients"},{"key":"2219_CR69","doi-asserted-by":"publisher","first-page":"639","DOI":"10.18388\/abp.2014_1825","volume":"61","author":"J Korbecki","year":"2014","unstructured":"Korbecki J, Baranowska-Bosiacka I, Gutowska I, Chlubek D (2014) Cyclooxygenase pathways. Acta Biochim Pol 61:639\u2013649","journal-title":"Acta Biochim Pol"},{"key":"2219_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.COLSURFB.2009.09.001","volume":"75","author":"A Kumari","year":"2010","unstructured":"Kumari A, Yadav SK, Yadav SC (2010) Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces 75:1\u201318. https:\/\/doi.org\/10.1016\/J.COLSURFB.2009.09.001","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2219_CR70","doi-asserted-by":"publisher","first-page":"162750","DOI":"10.1155\/2013\/162750","volume":"2013","author":"S Kumar","year":"2013","unstructured":"Kumar S, Pandey AK, Lu KP, Sastre J (2013) Chemistry and biological activities of flavonoids: an overview. Sci World J 2013:162750. https:\/\/doi.org\/10.1155\/2013\/162750","journal-title":"Sci World J"},{"key":"2219_CR72","doi-asserted-by":"publisher","first-page":"750","DOI":"10.17179\/EXCLI2019-1459","volume":"18","author":"J Lee","year":"2019","unstructured":"Lee J, Park SH, Lee J et al (2019) Differential effects of luteolin and its glycosides on invasion and apoptosis in MDA-MB-231 triple-negative breast cancer cells. EXCLI J 18:750. https:\/\/doi.org\/10.17179\/EXCLI2019-1459","journal-title":"EXCLI J"},{"key":"2219_CR76","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.ccell.2016.10.010","volume":"30","author":"SO Lim","year":"2016","unstructured":"Lim SO, Li CW, Xia W et al (2016) Deubiquitination and stabilization of PD-L1 by CSN5. Cancer Cell 30:925\u2013939. https:\/\/doi.org\/10.1016\/j.ccell.2016.10.010","journal-title":"Cancer Cell"},{"key":"2219_CR77","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2174\/156800908786241050","volume":"8","author":"Y Lin","year":"2008","unstructured":"Lin Y, Shi R, Wang X, Shen H-M (2008) Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targets 8:634\u2013646. https:\/\/doi.org\/10.2174\/156800908786241050","journal-title":"Curr Cancer Drug Targets"},{"key":"2219_CR73","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.biopha.2018.02.055","volume":"100","author":"S Li","year":"2018","unstructured":"Li S, Yuan S, Zhao Q et al (2018) Quercetin enhances chemotherapeutic effect of doxorubicin against human breast cancer cells while reducing toxic side effects of it. Biomed Pharmacother 100:441\u2013447. https:\/\/doi.org\/10.1016\/j.biopha.2018.02.055","journal-title":"Biomed Pharmacother"},{"key":"2219_CR78","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/S00262-024-03747-W","volume":"738 73","author":"C Liu","year":"2024","unstructured":"Liu C, Ruan Y, Huang R et al (2024) Efficacy and safety of immune checkpoint inhibitors in solid tumor patients combined with chronic coronary syndromes or its risk factor: a nationwide multicenter cohort study. Cancer Immunol Immunother 2024 738 73:159\u2013. https:\/\/doi.org\/10.1007\/S00262-024-03747-W","journal-title":"Cancer Immunol Immunother 2024"},{"key":"2219_CR74","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/J.CBI.2008.10.048","volume":"177","author":"W Li","year":"2009","unstructured":"Li W, Du B, Wang T et al (2009) Kaempferol induces apoptosis in human HCT116 colon cancer cells via the ataxia-telangiectasia mutated-p53 pathway with the involvement of p53 upregulated modulator of apoptosis. Chem Biol Interact 177:121\u2013127. https:\/\/doi.org\/10.1016\/J.CBI.2008.10.048","journal-title":"Chem Biol Interact"},{"key":"2219_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-9-274","author":"Y Li","year":"2010","unstructured":"Li Y, Yuan YY, Meeran SM, Tollefsbol TO (2010) Synergistic epigenetic reactivation of estrogen receptor-\u03b1 (ER\u03b1) by combined green tea polyphenol and histone deacetylase inhibitor in ER\u03b1-negative breast cancer cells. Mol Cancer. https:\/\/doi.org\/10.1186\/1476-4598-9-274","journal-title":"Mol Cancer"},{"key":"2219_CR79","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/J.TCB.2017.06.003","volume":"27","author":"CA Lyssiotis","year":"2017","unstructured":"Lyssiotis CA, Kimmelman AC (2017) Metabolic interactions in the tumor microenvironment. Trends Cell Biol 27:863\u2013875. https:\/\/doi.org\/10.1016\/J.TCB.2017.06.003","journal-title":"Trends Cell Biol"},{"key":"2219_CR80","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejmech.2015.05.004","volume":"98","author":"DK Mahapatra","year":"2015","unstructured":"Mahapatra DK, Bharti SK, Asati V (2015) Anti-cancer chalcones: structural and molecular target perspectives. Eur J Med Chem 98:69\u2013114. https:\/\/doi.org\/10.1016\/j.ejmech.2015.05.004","journal-title":"Eur J Med Chem"},{"key":"2219_CR81","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/NATURE07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454:436\u2013444. https:\/\/doi.org\/10.1038\/NATURE07205","journal-title":"Nature"},{"key":"2219_CR82","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","volume":"47","author":"W Mehnert","year":"2001","unstructured":"Mehnert W, M\u00e4der K (2001) Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 47:165\u2013196. https:\/\/doi.org\/10.1016\/S0169-409X(01)00105-3","journal-title":"Adv Drug Deliv Rev"},{"key":"2219_CR83","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1007\/S11095-010-0208-5","volume":"27","author":"G Merino","year":"2010","unstructured":"Merino G, Perez M, Real R et al (2010) In vivo inhibition of BCRP\/ABCG2 mediated transport of nitrofurantoin by the isoflavones genistein and daidzein: a comparative study in Bcrp1 (-\/-) mice. Pharm Res 27:2098\u20132105. https:\/\/doi.org\/10.1007\/S11095-010-0208-5","journal-title":"Pharm Res"},{"key":"2219_CR84","doi-asserted-by":"publisher","first-page":"100167","DOI":"10.1016\/J.CRPHAR.2023.100167","volume":"6","author":"SA Mir","year":"2024","unstructured":"Mir SA, Dar A, Hamid L et al (2024) Flavonoids as promising molecules in the cancer therapy: an insight. Curr Res Pharmacol Drug Discov 6:100167. https:\/\/doi.org\/10.1016\/J.CRPHAR.2023.100167","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"2219_CR88","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","volume":"50","author":"RH M\u00fcller","year":"2000","unstructured":"M\u00fcller RH, M\u00e4der K, Gohla S (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery\u2014a review of the state of the art. Eur J Pharm Biopharm 50:161\u2013177. https:\/\/doi.org\/10.1016\/S0939-6411(00)00087-4","journal-title":"Eur J Pharm Biopharm"},{"key":"2219_CR85","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/BDD.605","volume":"29","author":"YJ Moon","year":"2008","unstructured":"Moon YJ, Wang L, DiCenzo R, Morris ME (2008) Quercetin pharmacokinetics in humans. Biopharm Drug Dispos 29:205\u2013217. https:\/\/doi.org\/10.1002\/BDD.605","journal-title":"Biopharm Drug Dispos"},{"key":"2219_CR86","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/J.TIV.2005.06.048","volume":"20","author":"YJ Moon","year":"2006","unstructured":"Moon YJ, Wang X, Morris ME (2006) Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicol Vitro 20:187\u2013210. https:\/\/doi.org\/10.1016\/J.TIV.2005.06.048","journal-title":"Toxicol Vitro"},{"key":"2219_CR87","doi-asserted-by":"publisher","DOI":"10.1177\/10732748251406677","author":"S Mukherjee","year":"2025","unstructured":"Mukherjee S, Pati S, Dhar S et al (2025) The role of nuclear factor-\u03baB in cancer immunity and immunoediting. Cancer Control. https:\/\/doi.org\/10.1177\/10732748251406677","journal-title":"Cancer Control"},{"key":"2219_CR89","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/S00281-012-0342-8","volume":"35","author":"M Nakanishi","year":"2013","unstructured":"Nakanishi M, Rosenberg DW (2013) Multifaceted roles of PGE2 in inflammation and cancer. Semin Immunopathol 35:123\u2013137. https:\/\/doi.org\/10.1007\/S00281-012-0342-8","journal-title":"Semin Immunopathol"},{"key":"2219_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/MOLECULES27061873","author":"AA Neamtu","year":"2022","unstructured":"Neamtu AA, Maghiar TA, Alaya A et al (2022) A comprehensive view on the quercetin impact on colorectal cancer. Molecules. https:\/\/doi.org\/10.3390\/MOLECULES27061873","journal-title":"Molecules"},{"key":"2219_CR91","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.3748\/WJG.V25.I17.2029","volume":"25","author":"L Necula","year":"2019","unstructured":"Necula L, Matei L, Dragu D et al (2019) Recent advances in gastric cancer early diagnosis. World J Gastroenterol 25:2029\u20132044. https:\/\/doi.org\/10.3748\/WJG.V25.I17.2029","journal-title":"World J Gastroenterol"},{"key":"2219_CR92","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/SCIENCE.AAY9189","volume":"368","author":"D Nejman","year":"2020","unstructured":"Nejman D, Livyatan I, Fuks G et al (2020) The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science 368:973\u2013980. https:\/\/doi.org\/10.1126\/SCIENCE.AAY9189","journal-title":"Science"},{"key":"2219_CR93","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/J.CANLET.2017.10.037","volume":"413","author":"RT Netea-Maier","year":"2018","unstructured":"Netea-Maier RT, Smit JWA, Netea MG (2018) Metabolic changes in tumor cells and tumor-associated macrophages: a mutual relationship. Cancer Lett 413:102\u2013109. https:\/\/doi.org\/10.1016\/J.CANLET.2017.10.037","journal-title":"Cancer Lett"},{"key":"2219_CR94","doi-asserted-by":"publisher","first-page":"C569","DOI":"10.1152\/AJPCELL.00207.2015","volume":"309","author":"MZ Noman","year":"2015","unstructured":"Noman MZ, Hasmim M, Messai Y et al (2015) Hypoxia: a key player in antitumor immune response. a review in the theme: cellular responses to hypoxia. Am J Physiol - Cell Physiol 309:C569. https:\/\/doi.org\/10.1152\/AJPCELL.00207.2015","journal-title":"Am J Physiol - Cell Physiol"},{"key":"2219_CR95","doi-asserted-by":"publisher","first-page":"100558","DOI":"10.1016\/J.PHYPLU.2024.100558","volume":"4","author":"SIR Okoduwa","year":"2024","unstructured":"Okoduwa SIR, Abdulwaliyu I, Igiri BE et al (2024) Multi-therapeutic potential of flavonoids as an essential component in nutraceuticals for the treatment and management of human diseases. Phytomedicine Plus 4:100558. https:\/\/doi.org\/10.1016\/J.PHYPLU.2024.100558","journal-title":"Phytomedicine Plus"},{"key":"2219_CR96","doi-asserted-by":"publisher","DOI":"10.1017\/JNS.2016.41","author":"AN Panche","year":"2016","unstructured":"Panche AN, Diwan AD, Chandra SR (2016) Flavonoids: an overview. J Nutr Sci. https:\/\/doi.org\/10.1017\/JNS.2016.41","journal-title":"J Nutr Sci"},{"key":"2219_CR97","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.immuni.2018.03.007","volume":"48","author":"SA Patel","year":"2018","unstructured":"Patel SA, Minn AJ (2018) Combination cancer therapy with immune checkpoint blockade: mechanisms and strategies. Immunity 48:417\u2013433. https:\/\/doi.org\/10.1016\/j.immuni.2018.03.007","journal-title":"Immunity"},{"key":"2219_CR98","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/J.CMET.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB (2016) The Emerging Hallmarks of Cancer Metabolism. Cell Metab 23:27\u201347. https:\/\/doi.org\/10.1016\/J.CMET.2015.12.006","journal-title":"Cell Metab"},{"key":"2219_CR99","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.15252\/EMBR.201439246","volume":"15","author":"MW Pickup","year":"2014","unstructured":"Pickup MW, Mouw JK, Weaver VM (2014) The extracellular matrix modulates the hallmarks of cancer. EMBO Rep 15:1243\u20131253. https:\/\/doi.org\/10.15252\/EMBR.201439246","journal-title":"EMBO Rep"},{"key":"2219_CR100","doi-asserted-by":"publisher","DOI":"10.3390\/MOLECULES26072029","author":"LGS Ponte","year":"2021","unstructured":"Ponte LGS, Pavan ICB, Mancini MCS et al (2021) The hallmarks of flavonoids in cancer. Molecules. https:\/\/doi.org\/10.3390\/MOLECULES26072029","journal-title":"Molecules"},{"key":"2219_CR101","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1002\/PTR.6155","volume":"32","author":"A Rauf","year":"2018","unstructured":"Rauf A, Imran M, Khan IA et al (2018) Anticancer potential of quercetin: a comprehensive review. Phytother Res 32:2109\u20132130. https:\/\/doi.org\/10.1002\/PTR.6155","journal-title":"Phytother Res"},{"key":"2219_CR102","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1002\/JCP.25026","volume":"230","author":"MG Refolo","year":"2015","unstructured":"Refolo MG, D\u2019Alessandro R, Malerba N et al (2015) Anti proliferative and pro apoptotic effects of flavonoid quercetin are mediated by CB1 receptor in human colon cancer cell lines. J Cell Physiol 230:2973\u20132980. https:\/\/doi.org\/10.1002\/JCP.25026","journal-title":"J Cell Physiol"},{"key":"2219_CR103","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/J.EJMECH.2017.12.039","volume":"144","author":"A Rejhov\u00e1","year":"2018","unstructured":"Rejhov\u00e1 A, Opattov\u00e1 A, \u010cumov\u00e1 A et al (2018) Natural compounds and combination therapy in colorectal cancer treatment. Eur J Med Chem 144:582\u2013594. https:\/\/doi.org\/10.1016\/J.EJMECH.2017.12.039","journal-title":"Eur J Med Chem"},{"key":"2219_CR104","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/J.FREERADBIOMED.2010.09.006","volume":"49","author":"S Reuter","year":"2010","unstructured":"Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB (2010) Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 49:1603\u20131616. https:\/\/doi.org\/10.1016\/J.FREERADBIOMED.2010.09.006","journal-title":"Free Radic Biol Med"},{"key":"2219_CR105","doi-asserted-by":"publisher","first-page":"413087","DOI":"10.3389\/FPHAR.2018.01260\/FULL","volume":"9","author":"S Rezvantalab","year":"2018","unstructured":"Rezvantalab S, Drude NI, Moraveji MK et al (2018) PLGA-based nanoparticles in cancer treatment. Front Pharmacol 9:413087. https:\/\/doi.org\/10.3389\/FPHAR.2018.01260\/FULL","journal-title":"Front Pharmacol"},{"key":"2219_CR106","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/SCIENCE.AAR4060","volume":"359","author":"A Ribas","year":"2018","unstructured":"Ribas A, Wolchok JD (2018) Cancer immunotherapy using checkpoint blockade. Science 359:1350\u20131355. https:\/\/doi.org\/10.1126\/SCIENCE.AAR4060","journal-title":"Science"},{"key":"2219_CR107","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","volume":"178","author":"E Riquelme","year":"2019","unstructured":"Riquelme E, Zhang Y, Zhang L et al (2019) Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell 178:795\u2013806e12. https:\/\/doi.org\/10.1016\/j.cell.2019.07.008","journal-title":"Cell"},{"key":"2219_CR108","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/S1470-2045(19)30388-2","volume":"20","author":"C Robert","year":"2019","unstructured":"Robert C, Ribas A, Schachter J et al (2019) Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study. Lancet Oncol 20:1239\u20131251. https:\/\/doi.org\/10.1016\/S1470-2045(19)30388-2","journal-title":"Lancet Oncol"},{"key":"2219_CR109","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS23042034","author":"CV da Rocha","year":"2022","unstructured":"Rocha CV, Gon\u00e7alves V, da Silva MC et al (2022) PLGA-based composites for various biomedical applications. Int J Mol Sci. https:\/\/doi.org\/10.3390\/IJMS23042034","journal-title":"Int J Mol Sci"},{"key":"2219_CR110","doi-asserted-by":"publisher","DOI":"10.1111\/J.1750-3841.2011.02155.X","author":"L Rodr\u00edguez-Fragoso","year":"2011","unstructured":"Rodr\u00edguez-Fragoso L, Mart\u00ednez-Arismendi JL, Orozco-Bustos D et al (2011) Potential risks resulting from fruit\/vegetable-drug interactions: effects on drug-metabolizing enzymes and drug transporters. J Food Sci. https:\/\/doi.org\/10.1111\/J.1750-3841.2011.02155.X","journal-title":"J Food Sci"},{"key":"2219_CR111","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.bcp.2011.08.010","volume":"83","author":"M Russo","year":"2012","unstructured":"Russo M, Spagnuolo C, Tedesco I et al (2012) The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochem Pharmacol 83:6\u201315. https:\/\/doi.org\/10.1016\/j.bcp.2011.08.010","journal-title":"Biochem Pharmacol"},{"key":"2219_CR112","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/S41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E et al (2020) A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer 20:174\u2013186. https:\/\/doi.org\/10.1038\/S41568-019-0238-1","journal-title":"Nat Rev Cancer"},{"key":"2219_CR113","doi-asserted-by":"publisher","first-page":"122","DOI":"10.4103\/0973-7847.134247","volume":"8","author":"K Sak","year":"2014","unstructured":"Sak K (2014) Cytotoxicity of dietary flavonoids on different human cancer types. Pharmacogn Rev 8:122. https:\/\/doi.org\/10.4103\/0973-7847.134247","journal-title":"Pharmacogn Rev"},{"key":"2219_CR114","doi-asserted-by":"publisher","DOI":"10.3390\/PH12010011","author":"B Salehi","year":"2019","unstructured":"Salehi B, Fokou PVT, Sharifi-Rad M et al (2019) The therapeutic potential of naringenin: a review of clinical trials. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/PH12010011","journal-title":"Pharmaceuticals (Basel)"},{"key":"2219_CR115","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/S11010-012-1310-2","volume":"366","author":"HS Seo","year":"2012","unstructured":"Seo HS, Choi HS, Kim SR et al (2012) Apigenin induces apoptosis via extrinsic pathway, inducing p53 and inhibiting STAT3 and NF\u03baB signaling in HER2-overexpressing breast cancer cells. Mol Cell Biochem 366:319\u2013334. https:\/\/doi.org\/10.1007\/S11010-012-1310-2","journal-title":"Mol Cell Biochem"},{"key":"2219_CR116","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1017\/S002966511000162X","volume":"69","author":"M Serafini","year":"2010","unstructured":"Serafini M, Peluso I, Raguzzini A (2010) Flavonoids as anti-inflammatory agents. Proc Nutr Soc 69:273\u2013278. https:\/\/doi.org\/10.1017\/S002966511000162X","journal-title":"Proc Nutr Soc"},{"key":"2219_CR117","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1093\/jn\/131.7.1938","volume":"131","author":"ALA Sesink","year":"2001","unstructured":"Sesink ALA, O\u2019Leary KA, Hollman PCH (2001) Quercetin glucuronides but not glucosides are present in human plasma after consumption of quercetin-3-glucoside or quercetin-4\u2032-glucoside. J Nutr 131:1938\u20131941. https:\/\/doi.org\/10.1093\/jn\/131.7.1938","journal-title":"J Nutr"},{"key":"2219_CR118","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/J.IMMUNI.2019.06.021","volume":"51","author":"S Shalapour","year":"2019","unstructured":"Shalapour S, Karin M (2019) Pas de Deux: control of anti-tumor immunity by cancer-associated inflammation. Immunity 51:15\u201326. https:\/\/doi.org\/10.1016\/J.IMMUNI.2019.06.021","journal-title":"Immunity"},{"key":"2219_CR119","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1126\/SCIENCE.AAA8172","volume":"348","author":"P Sharma","year":"2015","unstructured":"Sharma P, Allison JP (2015) The future of immune checkpoint therapy. Science 348:56\u201361. https:\/\/doi.org\/10.1126\/SCIENCE.AAA8172","journal-title":"Science"},{"key":"2219_CR120","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1124\/DMD.108.023416","volume":"37","author":"D Si","year":"2009","unstructured":"Si D, Wang Y, Zhou YH et al (2009) Mechanism of CYP2C9 inhibition by flavones and flavonols. Drug Metab Dispos 37:629\u2013634. https:\/\/doi.org\/10.1124\/DMD.108.023416","journal-title":"Drug Metab Dispos"},{"key":"2219_CR121","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ejmech.2014.07.013","volume":"84","author":"M Singh","year":"2014","unstructured":"Singh M, Kaur M, Silakari O (2014) Flavones: an important scaffold for medicinal chemistry. Eur J Med Chem 84:206\u2013239. https:\/\/doi.org\/10.1016\/j.ejmech.2014.07.013","journal-title":"Eur J Med Chem"},{"key":"2219_CR122","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/NRGASTRO.2016.181","volume":"14","author":"S Singh","year":"2017","unstructured":"Singh S, Dulai PS, Zarrinpar A et al (2017) Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes. Nat Rev Gastroenterol Hepatol 14:110\u2013121. https:\/\/doi.org\/10.1038\/NRGASTRO.2016.181","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2219_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112442","author":"H Slika","year":"2022","unstructured":"Slika H, Mansour H, Wehbe N et al (2022) Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms. Biomed Pharmacother. https:\/\/doi.org\/10.1016\/j.biopha.2021.112442","journal-title":"Biomed Pharmacother"},{"key":"2219_CR124","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/S00280-011-1596-X","volume":"68","author":"D Staedler","year":"2011","unstructured":"Staedler D, Idrizi E, Kenzaoui BH, Juillerat-Jeanneret L (2011) Drug combinations with quercetin: doxorubicin plus quercetin in human breast cancer cells. Cancer Chemother Pharmacol 68:1161\u20131172. https:\/\/doi.org\/10.1007\/S00280-011-1596-X","journal-title":"Cancer Chemother Pharmacol"},{"key":"2219_CR125","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.phytochem.2004.04.025","volume":"65","author":"JF Stevens","year":"2004","unstructured":"Stevens JF, Page JE (2004) Xanthohumol and related prenylflavonoids from hops and beer: to your good health! Phytochemistry 65:1317\u20131330. https:\/\/doi.org\/10.1016\/j.phytochem.2004.04.025","journal-title":"Phytochemistry"},{"key":"2219_CR126","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/CAAC.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN Estimates of Incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/CAAC.21660","journal-title":"CA Cancer J Clin"},{"key":"2219_CR127","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/NRI.2017.142","volume":"18","author":"K Taniguchi","year":"2018","unstructured":"Taniguchi K, Karin M (2018) NF-\u03baB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol 18:309\u2013324. https:\/\/doi.org\/10.1038\/NRI.2017.142","journal-title":"Nat Rev Immunol"},{"key":"2219_CR128","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/IJC.22419","volume":"120","author":"SC Thomasset","year":"2007","unstructured":"Thomasset SC, Berry DP, Garcea G et al (2007) Dietary polyphenolic phytochemicals\u2013promising cancer chemopreventive agents in humans? A review of their clinical properties. Int J cancer 120:451\u2013458. https:\/\/doi.org\/10.1002\/IJC.22419","journal-title":"Int J cancer"},{"key":"2219_CR129","doi-asserted-by":"publisher","DOI":"10.1126\/SCIENCE.AAX0182","author":"SL Topalian","year":"2020","unstructured":"Topalian SL, Taube JM, Pardoll DM (2020) Neoadjuvant checkpoint blockade for cancer immunotherapy. Science. https:\/\/doi.org\/10.1126\/SCIENCE.AAX0182","journal-title":"Science"},{"key":"2219_CR130","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/MEDICINES5030093","volume":"5","author":"D Tungmunnithum","year":"2018","unstructured":"Tungmunnithum D, Thongboonyou A, Pholboon A, Yangsabai A (2018) Flavonoids and other phenolic compounds from medicinal plants for pharmaceutical and medical aspects: an overview. Med 2018 5:5:93. https:\/\/doi.org\/10.3390\/MEDICINES5030093","journal-title":"Med 2018"},{"key":"2219_CR132","doi-asserted-by":"publisher","DOI":"10.3390\/MOLECULES25225243","author":"A Ullah","year":"2020","unstructured":"Ullah A, Munir S, Badshah SL et al (2020) Important flavonoids and their role as a therapeutic agent. Molecules. https:\/\/doi.org\/10.3390\/MOLECULES25225243","journal-title":"Molecules"},{"key":"2219_CR133","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.3390\/PH18101486","volume":"18","author":"P Uniyal","year":"2025","unstructured":"Uniyal P, Akhtar A, Rawat R (2025) Flavonoid-based combination therapies and nano-formulations: an emerging frontier in breast cancer treatment. Pharmaceuticals 18:1486. https:\/\/doi.org\/10.3390\/PH18101486","journal-title":"Pharmaceuticals"},{"key":"2219_CR134","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","volume":"168","author":"MG Vander Heiden","year":"2017","unstructured":"Vander Heiden MG, DeBerardinis RJ (2017) Understanding the intersections between metabolism and cancer biology. Cell 168:657\u2013669. https:\/\/doi.org\/10.1016\/j.cell.2016.12.039","journal-title":"Cell"},{"key":"2219_CR135","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.3390\/CANCERS12082252","volume":"12","author":"E Varghese","year":"2020","unstructured":"Varghese E, Samuel SM, L\u00ed\u0161kov\u00e1 A et al (2020) Targeting glucose metabolism to overcome resistance to anticancer chemotherapy in breast cancer. Cancers (Basel) 12:2252. https:\/\/doi.org\/10.3390\/CANCERS12082252","journal-title":"Cancers (Basel)"},{"key":"2219_CR136","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/ONC.2009.421","volume":"29","author":"D Wang","year":"2010","unstructured":"Wang D, Dubois RN (2010) The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene 29:781\u2013788. https:\/\/doi.org\/10.1038\/ONC.2009.421","journal-title":"Oncogene"},{"key":"2219_CR137","doi-asserted-by":"publisher","first-page":"490","DOI":"10.2174\/1389200219666180307122945","volume":"19","author":"H Wang","year":"2018","unstructured":"Wang H, Cao G, Wang G, Hao H (2018a) Regulation of mammalian UDP-glucuronosyltransferases. Curr Drug Metab 19:490\u2013501. https:\/\/doi.org\/10.2174\/1389200219666180307122945","journal-title":"Curr Drug Metab"},{"key":"2219_CR138","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/J.AJPS.2017.08.004","volume":"13","author":"T Wang","year":"2018","unstructured":"Wang T, yang, Li Q, Bi Kshun (2018b) Bioactive flavonoids in medicinal plants: structure, activity and biological fate. Asian J Pharm Sci 13:12\u201323. https:\/\/doi.org\/10.1016\/J.AJPS.2017.08.004","journal-title":"Asian J Pharm Sci"},{"key":"2219_CR139","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/S10555-012-9347-Y","volume":"31","author":"CJ Weng","year":"2012","unstructured":"Weng CJ, Yen GC (2012) Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities. Cancer Metastasis Rev 31:323\u2013351. https:\/\/doi.org\/10.1007\/S10555-012-9347-Y","journal-title":"Cancer Metastasis Rev"},{"key":"2219_CR140","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1124\/DMD.104.000794","volume":"32","author":"JA Williams","year":"2004","unstructured":"Williams JA, Hyland R, Jones BC et al (2004) Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi\/AUC) ratios. Drug Metab Dispos 32:1201\u20131208. https:\/\/doi.org\/10.1124\/DMD.104.000794","journal-title":"Drug Metab Dispos"},{"key":"2219_CR141","doi-asserted-by":"publisher","first-page":"6125","DOI":"10.1158\/1078-0432.CCR-18-1481","volume":"24","author":"MCA Wouters","year":"2018","unstructured":"Wouters MCA, Nelson BH (2018) Prognostic significance of tumor-infiltrating B cells and plasma cells in human cancer. Clin Cancer Res 24:6125\u20136135. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1481","journal-title":"Clin Cancer Res"},{"key":"2219_CR142","doi-asserted-by":"publisher","DOI":"10.3390\/NU10111618","author":"N Yahfoufi","year":"2018","unstructured":"Yahfoufi N, Alsadi N, Jambi M, Matar C (2018) The immunomodulatory and anti-inflammatory role of polyphenols. Nutrients. https:\/\/doi.org\/10.3390\/NU10111618","journal-title":"Nutrients"},{"key":"2219_CR143","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/S00394-015-0950-X","volume":"55","author":"R Zamora-Ros","year":"2016","unstructured":"Zamora-Ros R, Knaze V, Rothwell JA et al (2016) Dietary polyphenol intake in Europe: the European prospective investigation into cancer and nutrition (EPIC) study. Eur J Nutr 55:1359\u20131375. https:\/\/doi.org\/10.1007\/S00394-015-0950-X","journal-title":"Eur J Nutr"},{"key":"2219_CR144","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1002\/CNCR.30615","volume":"123","author":"FF Zhang","year":"2017","unstructured":"Zhang FF, Haslam DE, Terry MB et al (2017) Dietary isoflavone intake and all-cause mortality in breast cancer survivors: the breast cancer family registry. Cancer 123:2070\u20132079. https:\/\/doi.org\/10.1002\/CNCR.30615","journal-title":"Cancer"},{"key":"2219_CR145","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/MCO2.104","volume":"2","author":"T Zhang","year":"2021","unstructured":"Zhang T, Ma C, Zhang Z et al (2021) NF-\u03baB signaling in inflammation and cancer. MedComm 2:618. https:\/\/doi.org\/10.1002\/MCO2.104","journal-title":"MedComm"},{"key":"2219_CR146","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1159\/000490025","volume":"47","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Yang W, Huang Y et al (2018) Evolving roles for targeting CTLA-4 in cancer immunotherapy. Cell Physiol Biochem 47:721\u2013734. https:\/\/doi.org\/10.1159\/000490025","journal-title":"Cell Physiol Biochem"},{"key":"2219_CR147","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/FTD.0B013E31815C16F5","volume":"29","author":"SF Zhou","year":"2007","unstructured":"Zhou SF, Xue CC, Yu XQ et al (2007) Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring. Ther Drug Monit 29:687\u2013710. https:\/\/doi.org\/10.1097\/FTD.0B013E31815C16F5","journal-title":"Ther Drug Monit"},{"key":"2219_CR149","doi-asserted-by":"publisher","first-page":"7762","DOI":"10.1021\/ACS.CHEMREV.7B00020","volume":"117","author":"C Zhuang","year":"2017","unstructured":"Zhuang C, Zhang W, Sheng C et al (2017) Chalcone: a privileged structure in medicinal chemistry. Chem Rev 117:7762\u20137810. https:\/\/doi.org\/10.1021\/ACS.CHEMREV.7B00020","journal-title":"Chem Rev"},{"key":"2219_CR148","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1002\/PTR.8217","volume":"38","author":"M Zhu","year":"2024","unstructured":"Zhu M, Sun Y, Su Y et al (2024) Luteolin: a promising multifunctional natural flavonoid for human diseases. Phyther Res 38:3417\u20133443. https:\/\/doi.org\/10.1002\/PTR.8217","journal-title":"Phyther Res"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02219-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02219-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02219-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:00:57Z","timestamp":1778857257000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02219-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":147,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2219"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02219-0","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"30 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}